0001209191-21-060550.txt : 20211015 0001209191-21-060550.hdr.sgml : 20211015 20211015162449 ACCESSION NUMBER: 0001209191-21-060550 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211013 FILED AS OF DATE: 20211015 DATE AS OF CHANGE: 20211015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POYHONEN JOHN CENTRAL INDEX KEY: 0001286100 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33221 FILM NUMBER: 211326318 MAIL ADDRESS: STREET 1: 11088 N TORREY PINES RD STREET 2: C/O SENOMYX INC CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/ CENTRAL INDEX KEY: 0000818033 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942875566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582514400 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AP PHARMA INC /DE/ DATE OF NAME CHANGE: 20010511 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-13 0 0000818033 HERON THERAPEUTICS, INC. /DE/ HRTX 0001286100 POYHONEN JOHN 4242 CAMPUS POINT COURT SUITE 200 SAN DIEGO CA 92121 0 1 0 0 President & CCO Common Stock 2021-10-13 4 M 0 1250 A 23452 D Common Stock 2021-10-13 4 F 0 433 10.55 D 23019 D Restricted Stock Units 2021-10-13 4 M 0 1250 0.00 D Common Stock 1250 15000 D Employee Stock Option (Right to Buy) 10.55 2021-10-13 4 A 0 92200 0.00 A 2031-10-13 Common Stock 92200 92200 D Restricted Stock Units 0.00 2021-10-13 4 A 0 55320 0.00 A Common Stock 55320 55320 D Restricted stock units convert into common stock on a one-for-one basis. Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant. The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. /s/ Lisa Peraza Attorney-in-fact for John Poyhonen 2021-10-15